Literature DB >> 18292534

Absence of CTL responses to early viral antigens facilitates viral persistence.

Anita Schildknecht1, Sarah Welti, Markus B Geuking, Lars Hangartner, Maries van den Broek.   

Abstract

CD8+ T cells are crucial for the control of intracellular pathogens such as viruses and some bacteria. Using lymphocytic choriomeningitis virus (LCMV) infection of mice--the prototypic arenavirus evolutionarily closely related to human Lassa fever and South American hemorrhagic fever viruses, we have shown previously that the kinetics of Ag presentation determine immunodominance of the LCMV-specific CTL response due to progressive exhaustion of LCMV nucleoprotein (NP)-specific CTL upon increasing viral load. In this study, we provide evidence that CTL against early LCMV NP-derived epitopes are more important in virus control than those against late glycoprotein-derived epitopes. We show that mice that are tolerant to all NP-derived T cell epitopes are severely compromised in their ability to control larger inocula of LCMV, supporting our hypothesis that CD8+ T cells specific for early viral Ags play a major role in acute virus control. Thus, the kinetics with which virus-derived T cell epitopes are presented has a strong impact on the efficacy of the antiviral immunity. This aspect should be taken into consideration for the development of vaccines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292534     DOI: 10.4049/jimmunol.180.5.3113

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression.

Authors:  Andreas Bergthaler; Lukas Flatz; Ahmed N Hegazy; Susan Johnson; Edit Horvath; Max Löhning; Daniel D Pinschewer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

3.  Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro.

Authors:  Melissa W Hayes; Ricardo Carrion; Jerritt Nunneley; Andrei E Medvedev; Maria S Salvato; Igor S Lukashevich
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.

Authors:  Shenghua Zhou; Anna M Cerny; Katherine A Fitzgerald; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

5.  Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers.

Authors:  Ricardo Carrion; Peter Bredenbeek; Xiaohong Jiang; Irina Tretyakova; Peter Pushko; Igor S Lukashevich
Journal:  J Vaccines Vaccin       Date:  2012-11-20

6.  Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.

Authors:  Catherine E Terrell; Michael B Jordan
Journal:  Blood       Date:  2013-05-09       Impact factor: 22.113

7.  Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

Authors:  Vanessa N Raabe; Gerrit Kann; Bruce S Ribner; Andres Morales; Jay B Varkey; Aneesh K Mehta; G Marshall Lyon; Sharon Vanairsdale; Kelly Faber; Stephan Becker; Markus Eickmann; Thomas Strecker; Shelley Brown; Ketan Patel; Philipp De Leuw; Gundolf Schuettfort; Christoph Stephan; Holger Rabenau; John D Klena; Pierre E Rollin; Anita McElroy; Ute Ströher; Stuart Nichol; Colleen S Kraft; Timo Wolf
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

8.  The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector Immunogenicity.

Authors:  Stephanie Darbre; Susan Johnson; Sandra Kallert; Paul-Henri Lambert; Claire-Anne Siegrist; Daniel D Pinschewer
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

9.  Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family.

Authors:  Kazi Faizul Azim; Tahera Lasker; Rahima Akter; Mantasha Mahmud Hia; Omar Faruk Bhuiyan; Mahmudul Hasan; Md Nazmul Hossain
Journal:  Heliyon       Date:  2021-05-19

Review 10.  Advanced vaccine candidates for Lassa fever.

Authors:  Igor S Lukashevich
Journal:  Viruses       Date:  2012-10-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.